Abstract 1854P
Background
Impaired perception of time has been associated with many psychiatric and neurological diseases. Time perception has been studied with different validated scales in the literature. However, the length of these scales limits its feasibility. The aim of our study was to evaluate the relationship of “1 minute” time perception with depression and anxiety in cancer patients receiving chemotherapy.
Methods
The cancer patients receiving active systemic therapy were included in the study. Time perception assessment was performed by testing how they perceived the 1-minute period. The patients were asked to guess the length of 1 minute by using a chronometer. Time perception duration (TPD) were recorded. The median 39 seconds was used to categorize patients as fast and slow time perception. Depression and anxiety were evaluated using the Hospital Anxiety and Depression Scale (HADS).
Results
In the study; 242 patients with a median age of 61 (33-88 years) were evaluated. In the TPD evaluation, the median estimation time was 39s (7-135sec) and 50.4% was found to be rapid time perception (<39sec). Anxiety and depression scores were recorded as high in 12% of the patients. There was no significant correlation between TPD and anxiety (r=0.027, p=0.68) and depression scores (r= 0.017, p= 0.79). TPD was similar between the groups with high and normal anxiety scores (39 vs 39 sec, p= 0.90) and those with short perception patients were similar in both groups (51.7% vs 50.2%, p=0.51). TPD was shorter in those with high depression scores (34 vs 40s, p= 0.37). Those with rapid TDP were more common in these patients, but this did not reach statistical significance (58.6% vs 49.3%, p= 0.22). In the multivariate analysis. Female gender and low income were found to be risk factors for high anxiety scores.
Conclusions
The 1-minute time perception assessment could not be shown to be effective in predicting depression and anxiety scores. In our study, in which the group with high depression/anxiety scores was low, the small sample size may be the reason for the insignificant result. Testing the efficacy of 1 minute time perception in larger groups can provide important data to the literature.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1604P - A comparative study of symptom prevalence between adults and elderly patients with advanced cancer diagnosis under palliative care: A single institution experience
Presenter: Hodan Abdullah
Session: Poster session 05
1605P - The impact of cancer pain on survival of lung cancer patients receiving immune checkpoint inhibitors
Presenter: Sichao Wang
Session: Poster session 05
1606P - Sarcopenia, depression, and modes of feeding among cancer patients
Presenter: Muhammad Khokhar
Session: Poster session 05
1607P - Patient perceptions of the efficacy, safety, and quality of the evidence available on medicinal cannabis: A survey of Australian cancer patients - comparing users to non-users
Presenter: Joseph Taylor
Session: Poster session 05
1608P - Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy
Presenter: Omer Dizdar
Session: Poster session 05
1609P - A machine learning-based prognostic model to predict survival in patients with advanced cancer admitted to an acute palliative care unit
Presenter: Eun Hee Jung
Session: Poster session 05
1610P - A new updated prognostic index for patients with brain metastases (BM) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology: METASNCore project
Presenter: Pablo Flores Paco
Session: Poster session 05
1611P - Family carers’ experiences with brain metastases: A longitudinal qualitative study
Presenter: Tonje Lundeby
Session: Poster session 05
1612P - Demonstrating the complexity of need and the effectiveness of integrated palliative care: An analysis of routinely collected patient centred outcome measures
Presenter: Joanne Hayes
Session: Poster session 05
1613P - The BreakThrough cancer malnutrition
Presenter: Stefano De Santis
Session: Poster session 05